The tiny ticks that cause the most Lyme disease are out in the US
Summer is here, meaning it's time to break out the tick protection along with the sunscreen.
Jul 13, 2022
0
7
Summer is here, meaning it's time to break out the tick protection along with the sunscreen.
Jul 13, 2022
0
7
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
Sep 15, 2016
0
3
January is National Glaucoma Awareness Month, which makes this a good time to learn more about treating this group of eye conditions.
Jan 5, 2022
0
13
Being physically active has major health benefits. But physical activity affects boys and girls differently. New research has examined the relationship between body fat and physical activity in children.
Jul 28, 2022
0
8
With Alex Trebek's recent announcement that his pancreatic cancer is in remission, many people have wondered if this difficult cancer is now easier to treat. Pancreatic cancer remains a major cancer killer, but advances are ...
May 31, 2019
0
4
A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying ...
Jun 21, 2011
0
0
Almost half of apparently healthy people between the ages of 40 and 50 could be accumulating fatty plaques—atheromas—in their arteries at a much faster rate than was previously thought. The Journal of the American College ...
Apr 6, 2020
0
5
A new study in JNCI Cancer Spectrum has identified a connection between prolonged time spent sitting while watching TV and increased risk of colorectal cancer for younger Americans.
Feb 5, 2019
0
8
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to a study published ...
May 26, 2012
0
0
A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly ...
Jun 4, 2023
0
54